CME

CME Group
D

CME

Arincen73/100B

CME Group cash flow statement 2000–2026

CME Group's free cash flow over the last twelve months was 4.33B USD: operating cash flow of 4.43B USD less 93.70M USD of capital spending. That is 62.1% of its revenue and 12.00 a share.

Operating cash flow Free cash flow

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Net income
4.42B4.07B3.53B3.23B2.69B2.64B2.11B2.12B1.96B4.06B1.53B
Depreciation and amortization
—330.90M336.80M352.60M362.60M385.40M464.40M473.30M248.70M208.50M225.30M
Stock-based compensation
—94.80M89.50M82.90M84.30M75.20M96.00M73.10M96.50M58.00M66.20M
Change in working capital
-28.40M99.70M-191.60M-95.20M-95.20M-161.80M59.20M-34.60M49.70M-16.70M-3.30M
Change in receivables
-145.20M-67.10M-39.40M-51.50M-51.10M-45.70M28.20M60.80M-65.50M6.00M-8.10M
Change in inventory
—0.000.000.000.000.00-19.20M-17.70M73.70M-1.50M24.50M
Change in payables
-7.20M-8.10M-10.70M-30.80M72.50M-18.60M7.40M-54.10M32.30M5.10M-2.60M
Change in other working capital
124.00M174.90M-141.50M-12.90M-116.60M-97.50M42.80M-23.60M9.20M-26.30M-17.10M
Other non-cash items
-299.20M-314.40M-3.60M-37.70M36.50M-568.10M31.20M48.90M-32.10M-115.00M-23.30M
Operating cash flow
4.43B4.28B3.69B3.45B3.06B2.40B2.72B2.67B2.44B1.84B1.72B
Operating cash flow growth
+6.39%+15.89%+6.85%+13.02%+27.21%-11.53%+1.60%+9.51%+32.62%+7.25%+13.24%
Capital expenditure
-93.70M-83.50M-94.00M-76.40M-89.70M-127.20M-197.50M-245.60M-116.70M-81.90M-91.80M
Acquisitions
—1.58B9.90M95.50M-402.00M144.70M20.80M89.60M-1.77B-1.30M-300.00K
Purchases of investments
-10.90M-6.00M-4.50M-4.10M-4.40M-7.80M-11.10M-15.40M-10.00M-3.00M-45.90M
Sales and maturities of investments
6.50M7.90M6.00M5.90M6.30M9.40M12.30M18.80M11.80M266.10M191.70M
Other investing
—0.000.000.000.0039.30M0.000.000.00261.80M145.50M
Investing cash flow
1.48B1.50B-82.60M20.90M-489.80M58.40M-175.50M-152.60M-1.89B179.90M53.70M
Debt issued (repaid)
—-9.40M0.00-16.40M-15.20M0.00-304.60M-661.70M1.12B0.000.00
Shares issued
—0.000.000.000.00965.00M0.0036.80M398.40M36.70M51.80M
Share buybacks
-2.02B-266.10M-33.00M-21.40M-24.80M0.00-41.40M-36.80M0.000.000.00
Dividends paid
-4.09B-3.93B-3.58B-3.24B-2.63B-2.19B-2.11B-1.70B-2.15B-1.99B-1.79B
Other financing
6.08B60.72B8.69B-45.07B-22.71B71.13B-2.20M53.60M-447.90M-28.50M11.70M
Financing cash flow
-18.50M56.51B5.08B-48.34B-25.38B69.91B-2.46B-2.34B-1.08B-1.99B-1.59B
Net change in cash
8.82B62.29B8.68B-44.86B-22.82B72.37B81.90M179.40M-528.80M35.00M176.00M
Free cash flow
4.33B4.19B3.60B3.38B2.97B2.28B2.52B2.43B2.32B1.76B1.62B
Free cash flow growth
+6.10%+16.60%+6.49%+13.86%+30.38%-9.65%+3.75%+4.44%+32.16%+8.27%+15.92%
Free cash flow margin
62.15%64.31%58.67%60.54%59.10%48.51%51.56%49.86%53.93%48.25%45.18%
Free cash flow per share
12.0011.649.999.398.266.347.026.786.765.174.79
Free cash flow per share growth
+5.85%+16.51%+6.36%+13.76%+30.28%-9.75%+3.66%+0.21%+30.81%+7.87%+15.56%
Interest paid
140.40M135.60M129.90M129.90M133.20M133.30M133.30M146.30M108.30M84.80M84.80M
Income taxes paid
1.33B1.16B1.20B1.11B973.40M755.00M652.70M591.20M577.40M762.80M706.70M

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about CME Group's cash flow

Source: Financial Modeling Prep